// App-Quantinova.ai

: A Comparison of Venous Thromboembolism (VTE) and Arterial Events between Ixazomib, Lenalidomide and Dexamthosone (ILD) and Lenalidomide and Dexamethosone (LD) Chemotherapy in Multiple Myeloma: Single Centre Experience

Researchers

Presenter

  • Z. Sayar

Principal Investigators

  • K. Yi

  • S. Cheesman

  • N. Rabin

Medical Centers

  • University College Hospital, Department of Thrombosis and Haemostasis, London, United Kingdom

  • University College London Hospital, Department of Pathology, London, United Kingdom

  • University College London Hospital, Department of Pathology, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Lenalidomide

  • Ixazomib

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved